BriaCell Therapeutics Corp. BCTX
Set alert
3.09 USD +0.05 +1.64%
At close · Nov 2
3.08 -0.01 -0.32%
After hours · Nov 2, 4:00 PM ET
3.05 Day range 3.20
2.60 52-week range 13.09
- YTD
- -56.54%
- 1 year
- -71.91%
- Open
- 3.07
- Prev close
- 3.04
- Mkt cap
- 26.98M
- Vol
- 60.10K
- Avg vol
- 266.69K
- EPS
- -6.97
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.05
- High
- 3.20
- Forward P/E
- -1.38
- Beta
- 1.82
- Short ratio
- 0.77
- Inst. own
- 4.65%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 28, 2024
- 50-d avg
- 0.7918
- 200-d avg
- 1.27
- 1y target
- 15.00
3M chart
Signals (20)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 6, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
Financial health
Altman Z-Score
-10.64 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -0.5×
FY 2017 5y median -2.6× FY 2026
P/S 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 1.1×
FY 2017 5y median 0.6× FY 2026
P/FCF -0.6×
FY 2017 5y median -3.7× FY 2026
EV/EBITDA -0.2×
FY 2017 5y median -25.3× FY 2026
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -167.0%
FY 2017 5y median -27.1% FY 2026
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -212.8%
FY 2017 5y median -148.4% FY 2026
ROIC -228.3%
FY 2017 5y median -91.8% FY 2026
ROA -148.0%
FY 2017 5y median -74.7% FY 2026
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2026
Operating Income 5.6%
FY 2017 FY 2026
EPS (diluted) 88.9%
FY 2017 FY 2026
Free Cash Flow 26.3%
FY 2017 FY 2026
Financial Health
Current Ratio 2.8×
FY 2017 5y median 5.0× FY 2026
Quick Ratio 2.8×
FY 2017 5y median 5.0× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.3×
FY 2017 5y median 0.4× FY 2026
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-07-31
